Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review
Open Access
- 30 April 2024
- journal article
- case report
- Published by MDPI AG in Microorganisms
- Vol. 12 (5) , 909
Abstract
Three patients with relapsing and remitting borreliosis, babesiosis, and bartonellosis, despite extended anti-infective therapy, were prescribed double-dose dapsone combination therapy (DDDCT) for 8 weeks, followed by one or several two-week courses of pulsed high-dose dapsone combination therapy (HDDCT). We discuss these patients’ cases to illustrate three important variables required for long-term remission. First, diagnosing and treating active co-infections, including Babesia and Bartonella were important. Babesia required rotations of multiple anti-malarial drug combinations and herbal therapies, and Bartonella required one or several 6-day HDDCT pulses to achieve clinical remission. Second, all prior oral, intramuscular (IM), and/or intravenous (IV) antibiotics used for chronic Lyme disease (CLD)/post-treatment Lyme disease syndrome (PTLDS), irrespective of the length of administration, were inferior in efficacy to short-term pulsed biofilm/persister drug combination therapy i.e., dapsone, rifampin, methylene blue, and pyrazinamide, which improved resistant fatigue, pain, headaches, insomnia, and neuropsychiatric symptoms. Lastly, addressing multiple factors on the 16-point multiple systemic infectious disease syndrome (MSIDS) model was important in achieving remission. In conclusion, DDDCT with one or several 6–7-day pulses of HDDCT, while addressing abnormalities on the 16-point MSIDS map, could represent a novel effective clinical and anti-infective strategy in CLD/PTLDS and associated co-infections including Bartonella.Keywords
Funding Information
- MSIDS Research Foundation (MRF)
This publication has 253 references indexed in Scilit:
- Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVIDJAMA, 2024
- Time to Treat the Climate and Nature Crisis as One Indivisible Global Health EmergencyJAMA Network Open, 2023
- Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 ConditionJAMA Internal Medicine, 2023
- Dapsone‐induced methemoglobinemia—A case reportClinical Case Reports, 2021
- Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseaseArthritis Care & Research, 2020
- Imaging analysis of Bartonella species in the skin using single-photon and multi-photon (second harmonic generation) laser scanning microscopyClinical Case Reports, 2020
- Dapsone‐induced methemoglobinemiaCancer, 2011
- Concurrent Infection of the Central Nervous System by Borrelia burgdorferi and Bartonella henselaeArchives of Neurology, 2001
- Concurrent Lyme Disease and BabesiosisJAMA, 1996
- Persistence of borrelia burgdorferi in ligamentous tissue from a patient with chronic lyme borreliosisArthritis & Rheumatism, 1993